Stay updated with breaking news from Program On Regulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This Viewpoint documents the history, value, and success of the 340B Pricing Program, which is under threat from pharmaceutical corporations’ withdrawal and fro
The Supreme Court Thursday blocked the Biden administration’s vaccine mandate for large employers. What happens now?
This will greatly improve access, but not for everyone," says Daniel Grossman, a University of California, San Francisco researcher.